Battle gets fiercer over drug market

Domestic and foreign drug makers will wage fiercer campaigns to raise their market share as many global makers' blockbuster products coming off patent within this year.

The industry's top players, including Dong A, Hanmi, Yuhan and Green Cross, may see a steep hike in sales on the back of their possible generic releases.

“It's going to get tougher to live off of copied drugs because paten...